Genezen and Optieum Join Forces for Innovative CAR-T Therapy Manufacturing in Glioblastoma Treatment Explore the partnership between Genezen and Optieum for the cGMP manufacturing of a revolutionary CAR-T therapy targeting glioblastoma, enhancing treatment options.

Genezen and Optieum Join Forces for Innovative CAR-T Therapy Manufacturing in Glioblastoma Treatment #USA #Indianapolis #CAR-T_therapy #Genezen #Optieum